Oct 05, 2021 / 02:30PM GMT
Geulah Livshits - Chardan Capital Markets LLC - Analyst
It's now my pleasure to introduce our next fireside chat guest. From MeiraGTx, we have Dr. Zandy Forbes, President and Chief Executive Officer. Thank you, Zandy, for joining us today.
Zandy Forbes - MeiraGTx Holdings PLC - President & CEO
Thank you for having me. I'm happy to be here.
Geulah Livshits - Chardan Capital Markets LLC - Analyst
So Zandy, maybe we can start off by you providing us with a couple minutes of introductory comments on Meira and as well perhaps comment on any recent business developments and upcoming catalysts that we should keep in mind.
Zandy Forbes - MeiraGTx Holdings PLC - President & CEO
Thank you. So Meira is a gene therapy company currently focused in AAV. We have six clinical programs, with two entering pivotal studies. We have four programs in rare eye diseases. Our rare eye disease franchise is partnered with Janssen and our lead program there is in RPGR. We have a deep
MeiraGTx Holdings PLC at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers